OPKO Health (XTAE:OPK) Inventories, Finished Goods: ₪120 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:OPK OPKO Health Inc XTAE:OPK
51 GF Score
Price ₪4.38
GF Value ₪3.31
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is OPKO Health Inventories, Finished Goods?

OPKO Health XTAE:OPK -1.33% 51 Inventories, Finished Goods is ₪120 Mil as of Jun. 2026. GuruFocus rates XTAE:OPK with a GF Score™ of 51/100 and a GF Value™ of ₪3.31 (Significantly Overvalued). The stock has 8 warning signs investors should review.

OPKO Health's quarterly finished goods increased from Dec. 2025 (₪132 Mil) to Mar. 2026 (₪132 Mil) but then declined from Mar. 2026 (₪132 Mil) to Jun. 2026 (₪120 Mil).

OPKO Health's annual finished goods declined from Dec. 2023 (₪107 Mil) to Dec. 2024 (₪97 Mil) but then increased from Dec. 2024 (₪97 Mil) to Dec. 2025 (₪132 Mil).

OPKO Health Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for OPKO Health's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Inventories, Finished Goods Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132.22 111.34 106.67 96.86 131.88

OPKO Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.51 126.67 131.88 132.16 119.94
XTAE:OPK
51GF Score
OPKO Health Inc XTAE:OPK
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OPKO Health Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₪120 Mil mean?
OPKO Health (XTAE:OPK) has a Inventories, Finished Goods of ₪120 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on OPKO Health and its competitors.
Is OPKO Health's Inventories, Finished Goods too high?
OPKO Health's current Inventories, Finished Goods is ₪120 Mil. Overall, OPKO Health has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Inventories, Finished Goods compare to CSTL and FRNM?
OPKO Health's Inventories, Finished Goods of ₪120 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Diagnostics & Research company?
A good Inventories, Finished Goods depends on the Medical Diagnostics & Research industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on OPKO Health and its competitors. OPKO Health's current Inventories, Finished Goods is ₪120 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (XTAE:OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is ₪3.31, compared to a current price of ₪4.38 — trading 32.2% above its estimated fair value. The current Inventories, Finished Goods is ₪120 Mil. OPKO Health's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For OPKO Health (XTAE:OPK), the current Inventories, Finished Goods is ₪120 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (XTAE:OPK) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of ₪4.38 is trading 32.2% above its estimated GF Value™ of ₪3.31. GuruFocus considers OPKO Health to be Significantly Overvalued.

Key valuation signals for XTAE:OPK:

  • Inventories, Finished Goods: ₪120 Mil
  • GF Value™: ₪3.31 vs. price of ₪4.38 (32.2% above fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the XTAE:OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
51GF Score

Get the complete analysis for XTAE:OPK

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪4.38
Price
₪3.31
GF Value